Evotec AG (investor - Corporate Investor)
See something wrong or missing? Let us know
Offices:Hamburg
Evotec SE is a publicly listed drug discovery and development company that operates globally, largely through external alliances with pharmaceutical and biotechnology companies, academic institutions, patient advocacy groups, and venture capitalists.
Average round investment:48.9M USD
Average number per year:1.5
Mostly invests in:
United Kingdom (6)
Biotech (9)
United Kingdom (6)
Biotech (9)
See the entire list
Showing 3 of 9 tracked investments in:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Evotec AG mostly invests with:
You need an account to access this feature. Log in or create one from here.
Do you have a question? Talk to us.
Investors with similar profile to Evotec AG
| Name | Criteria | |
|---|---|---|
![]() |
415 Capital
79%
|
|
![]() |
Metellus AG
79%
|
|
![]() |
Perscitus LLP
79%
|
|
![]() |
Shasta Ventures
79%
|
|
![]() |
TruVenturo
79%
|
|
![]() |
Wachstumsfonds Bayern
79%
|
|
![]() |
Wheatsheaf Group
79%
|
|
![]() |
Cumberland VC
79%
|
|
![]() |
Delphi VC
79%
|
|
![]() |
Digitalis Ventures
79%
|
|

Aptadir Therapeutics
Carrick Therapeutics

Belgium
Netherlands
Austria
Denmark
Estonia
Finland
Iceland
Latvia
Lithuania
Norway
Sweden
France
Portugal
Spain